Successful Treatment with Concurrent Antithyroid Drugs and Radioactive Iodine Treatment in Severe Graves’ Disease: 3 Case Reports
Article Sidebar
Published:
Jun 1, 2018
Keywords:
concurrent antithyroid drug and radioactive iodine severe Graves’ disease
Main Article Content
Abstract
Three cases of severe Graves’ disease were successfully treated with concurrent antithyroid drugs and radioactive iodine. Our team provided lower dose of antithyroid drugs prior to radioactive iodine treatment and administered a fixed dose of radioiodine (30 milicuries) to each patient. All patients were successfully treated within 6 months. No severe complications were is observed.
Article Details
How to Cite
Parklug, P., Kwancharoen, R., & Vidayavad, T. (2018). Successful Treatment with Concurrent Antithyroid Drugs and Radioactive Iodine Treatment in Severe Graves’ Disease: 3 Case Reports. Vajira Medical Journal : Journal of Urban Medicine, 62(3), 245–250. Retrieved from https://he02.tci-thaijo.org/index.php/VMED/article/view/195296
Section
Case Report
References
1. Bahn RS, Bruch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, el al. Hyperthyroidism and other causes of thyrotoxicosis: Management guidelines of the American thyroid association and American association of clinical endocrinologists. Endocr Pract. 2011; 17.
2. Vanderpump MPJ. The epidermology of thyroid disease: British medical Bulletin 2011;99: 39-51
3. มาคุ้มครอง โปษยะจินดา. การตรวจและรักษาโรคของต่อมไทรอยด์ด้วยสารกัมมันตภาพรังสี.กรุงเทพมหานคร:จรัลสนิทวงศ์การพิมพ์ จำกัด; พ.ศ. 2551. p.80-227.
4. Meier DA, Brill DR, Becker DY, Clarke SEM, Silberstein EB, Royal HD, et al. Procedure guideline for therapy of thyroid disease with 131Iodine. J Nucl Med. 2002;43: 856-61.
5. Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, et al. Antithyroid drug and Graves’ disease; a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab. 1990; 70 (3): 675-9.
6. Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostward E, Buell U. Radioiodine therapy in Graves’ disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid .1999;9(12): 1181-8.
7. Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, et al. Success rate of radioiodine therapy in Graves ’ disease: the influence of thyrostatic Medication. J Clin Endocrinol Metab. 1999; 84 (4): 1229-33.
8. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. The effect of propylthiouracil on subsequence radioactive iodine therapy in Graves’ disease. Clin Endocrinol (Oxford). 1997;47: 425-30.
2. Vanderpump MPJ. The epidermology of thyroid disease: British medical Bulletin 2011;99: 39-51
3. มาคุ้มครอง โปษยะจินดา. การตรวจและรักษาโรคของต่อมไทรอยด์ด้วยสารกัมมันตภาพรังสี.กรุงเทพมหานคร:จรัลสนิทวงศ์การพิมพ์ จำกัด; พ.ศ. 2551. p.80-227.
4. Meier DA, Brill DR, Becker DY, Clarke SEM, Silberstein EB, Royal HD, et al. Procedure guideline for therapy of thyroid disease with 131Iodine. J Nucl Med. 2002;43: 856-61.
5. Allannic H, Fauchet R, Orgiazzi J, Madec AM, Genetet B, Lorcy Y, et al. Antithyroid drug and Graves’ disease; a prospective randomized evaluation of the efficacy of treatment duration. J Clin Endocrinol Metab. 1990; 70 (3): 675-9.
6. Sabri O, Zimny M, Schreckenberger M, Reinartz P, Ostward E, Buell U. Radioiodine therapy in Graves’ disease patients with large diffuse goiters treated with or without carbimazole at the time of radioiodine therapy. Thyroid .1999;9(12): 1181-8.
7. Sabri O, Zimny M, Schulz G, Schreckenberger M, Reinartz P, Willmes K, et al. Success rate of radioiodine therapy in Graves ’ disease: the influence of thyrostatic Medication. J Clin Endocrinol Metab. 1999; 84 (4): 1229-33.
8. Hancock LD, Tuttle RM, LeMar H, Bauman J, Patience T. The effect of propylthiouracil on subsequence radioactive iodine therapy in Graves’ disease. Clin Endocrinol (Oxford). 1997;47: 425-30.